• 原料直供
• 试剂商城
• 直接询价

相关文献及参考

• [2]. Tortella FC, et, al. Dextromethorphan and carbetapentane: centrally acting non-opioid antitussive agents with novel anticonvulsant properties. Brain Res. 1986 Sep 24;383(1-2):314-8.
• [3]. Calderon SN, et, al. Novel 1-phenylcycloalkanecarboxylic acid derivatives are potent and selective sigma 1 ligands. J Med Chem. 1994 Jul 22;37(15):2285-91.
• [4]. Brown C, et, al. Antitussive activity of sigma-1 receptor agonists in the guinea-pig. Br J Pharmacol. 2004 Jan;141(2):233-40.
• [1]. Mohamed SH, et, al. Extraction-free spectrophotometric assay of the antitussive drug pentoxyverine citrate using sulfonephthalein dyes. Spectrochim Acta A Mol Biomol Spectrosc. 2019 Nov 5;222:117186.
• [1]. Mohamed SH, et, al. Extraction-free spectrophotometric assay of the antitussive drug pentoxyverine citrate using sulfonephthalein dyes. Spectrochim Acta A Mol Biomol Spectrosc. 2019 Nov 5;222:117186.
• [2]. Tortella FC, et, al. Dextromethorphan and carbetapent

安全信息

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Intravenous
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 13 mg/kg
TOXIC EFFECTS :
   Behavioral - convulsions or effect on seizure threshold
   Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
   JPPMAB Journal of Pharmacy and Pharmacology.  (Pharmaceutical Soc. of Great
   Britain, 1 Lambeth High St., London SEI 7JN, UK)  V.1-    1949-
   Volume(issue)/page/year: 9,446,1957

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 150 mg/kg
TOXIC EFFECTS :
   Behavioral - convulsions or effect on seizure threshold
   Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
   JPPMAB Journal of Pharmacy and Pharmacology.  (Pharmaceutical Soc. of Great
   Britain, 1 Lambeth High St., London SEI 7JN, UK)  V.1-    1949-
   Volume(issue)/page/year: 9,446,1957

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 130 mg/kg
TOXIC EFFECTS :
   Behavioral - convulsions or effect on seizure threshold
   Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
   JPPMAB Journal of Pharmacy and Pharmacology.  (Pharmaceutical Soc. of Great
   Britain, 1 Lambeth High St., London SEI 7JN, UK)  V.1-    1949-
   Volume(issue)/page/year: 9,446,1957

其他信息

• MSDS 信息:2-(2-Diethylaminoethoxy)ethyl 1-phenylcyclopentane-1-carboxylate(77-23-6).msds
• Sigma Aldrich:77-23-6(sigmaaldrich)
• 上游原料:无水氯化钙 --> 二乙胺 --> 三氯乙烯 --> 1-苯基环戊烷羧酸 --> 1,4-二溴丁烷 --> 氰苄 --> 1-苯基-1-氰基环戊烷 --> Α-苯基环戊烷甲酰氯 --> 芝麻酚
• 用途一:为非麻醉性中枢镇咳药。该品与枸櫞酸喷托维林，又称咳必清。这是一类非成瘾性镇咳药，镇咳疗效次于可待因，多和来治疗上呼吸道感染引起的急性、轻度咳嗽和百日咳，可减少支气管分泌。该品毒性低微。
• MOL 文件:77-23-6.mol
• 方法一:由四氢呋喃经开环、溴化、环合、水解、氯化、酯化而得。1.开环、溴化将四氢呋喃滴加到氢溴酸中，滴加硫酸，反应然后冷至室温，分取下层液，用纯碱溶液洗至中性。加无水氯化钙脱水后，过滤得1,4-二溴丁烷。2.环合将氰苄加入干燥的反应锅内，缓缓加入1,4-二溴丁烷。得1-苯基-1-氰基环戊烷。3.水解将水加入反应锅，并在搅拌下加入硫酸和1-苯基-1-氰基环戊烷得1-苯基环戊烷羧酸。4.氯化将1-苯基环戊烷羧酸溶于无水三氯乙烯中，并在搅拌下加入三氯化磷。反应后静置冷却分层，取上层清液减压蒸馏，回收三氯乙烯至尽，得1-苯基环戊烷甲酰氯。5.酯化将1-苯基环戊烷甲酰氯加入干燥的反应锅内，滴加二乙胺基乙氧基乙醇，酯化完成后，用酸碱处理、活性炭得油状物喷托维林。